Continuous tumour volume improves prognostic stratification beyond AJCC stage and MLPA cytogenetic profile in uveal melanoma
British Journal of Ophthalmology · 04.05.2026 · bjo-2026-329615
DOI: 10.1136/bjo-2026-329615 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, online erschienen am 04.05.2026. Verfasst von Armando Gutiérrez-Cuesta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the prognostic value of estimated tumour volume as a continuous biomarker in uveal melanoma and to compare its discriminative performance with the American Joint Committee on Cancer (AJCC) staging and multiplex ligation-dependent probe amplification (MLPA)-based genetic risk classification.
Methods
This retrospective cohort study included consecutive patients with choroidal or ciliary body melanoma treated between 2016 and 2024 at a tertiary ocular oncology centre. Tumour volume (mm³) was calculated from baseline ultrasonography using an ellipsoidal (oval-base) approximation. The primary endpoint was metastasis-free survival (MFS). Survival was analysed using Kaplan-Meier methods and Cox regression. In the genetic subset, Firth-penalised Cox regression was applied. Prognostic discrimination was assessed using Harrell’s concordance index (C-index) for AJCC stage, tumour volume, MLPA profile and combined models.
Results
A total of 237 patients were included (mean age 65.5±13.8 years; 54.0% female). Median follow-up was 61.0 months, and 64 patients developed metastasis during follow-up. Higher tumour volume was significantly associated with worse MFS, corresponding to an approximately 10% increase in hazard per 100 mm³ (HR 1.10; 95% CI 1.05 to 1.13; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain.
- Surgical Retina and Adult Intraocular Tumors Unit, Department of Ophthalmology, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Coruña, Spain manuelfrancisco.bande@usc.es.
- University of Santiago de Compostela, Santiago de Compostela, Spain, Santiago de Compostela, Coruña, Spain.
- Fundación Pública Galega de Medicina Xenómica, CHUS/SERGAS, Santiago de Compostela, Spain.
- Surgical Retina and Adult Intraocular Tumors Unit, Department of Ophthalmology, Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Coruña, Spain.
- Grupo Obesidómica, Laboratorio de Endocrinología Molecular y Celular, Hospital Clínico Universitario de Santiago (CHUS/SERGAS), Spain, Santiago de Compostela, Coruña, Spain.
Zitieren
APA
Gutiérrez-Cuesta, A., Bande, M. F., Silva-Rodríguez, P., Mera, P., Marticorena, J., Pardo, M., & Blanco-Teijeiro, M. J. (2026). Continuous tumour volume improves prognostic stratification beyond AJCC stage and MLPA cytogenetic profile in uveal melanoma. British Journal of Ophthalmology, bjo-2026-329615. https://doi.org/10.1136/bjo-2026-329615
Vancouver
Gutiérrez-Cuesta A, Bande MF, Silva-Rodríguez P, Mera P, Marticorena J, Pardo M, et al. Continuous tumour volume improves prognostic stratification beyond AJCC stage and MLPA cytogenetic profile in uveal melanoma. British Journal of Ophthalmology. 2026:bjo-2026-329615. doi:10.1136/bjo-2026-329615
BibTeX
@article{GutirrezCuesta2026,
author = {Gutiérrez-Cuesta, Armando and Bande, Manuel F and Silva-Rodríguez, Paula and Mera, Purificación and Marticorena, Joaquín and Pardo, María and Blanco-Teijeiro, María José},
title = {Continuous tumour volume improves prognostic stratification beyond AJCC stage and MLPA cytogenetic profile in uveal melanoma},
journal = {British Journal of Ophthalmology},
year = {2026},
pages = {bjo--2026--329615},
doi = {10.1136/bjo-2026-329615}
}
EUVIMED